Hemodialysis Consumables Market Insights
The hemodialysis consumables market is positioned for continued growth, primarily driven by the rising prevalence of ESRD and the increasing global burden of diabetes and hypertension. With over 4.1 million patients receiving dialysis treatments worldwide, of which 89% are undergoing hemodialysis, the demand for effective renal replacement therapies is higher than ever. According to the U.S. Renal Data System, the prevalence of ESRD nearly doubled between 2001 and 2021.
Diabetes is a major contributor to the increasing ESRD rates, accounting for more than 60% of new cases in 2021. The International Diabetes Federation forecasts a 46% rise in the global prevalence of diabetes by 2045, highlighting the long-term demand for hemodialysis. Additionally, hypertension—which affected approximately 1.28 billion individuals worldwide in 2023—is the second most common cause of ESRD, particularly in lower-income countries.
The market’s competitive landscape features leading suppliers such as Baxter and Fresenius, who provide a range of products, including consumables and dialysis equipment. Baxter is currently exploring strategic options regarding its Kidney Care and Acute Therapies business, which could lead to shifts in market dynamics and opportunities for other players to expand their footprint.
